Literature DB >> 11207505

Review article: a drug therapy for the prevention of variceal haemorrhage.

D Tripathi1, P C Hayes.   

Abstract

The development of varices is a major complication of cirrhosis, and variceal haemorrhage has a high mortality. There have been major advances in the primary and secondary prevention of variceal haemorrhage over the last 20 years involving endoscopic, radiological and pharmacological approaches. This review concentrates principally on drug therapy, particularly on the numerous haemodynamic studies. Many of these drugs have not been studied in clinical trials, but provide data about the underlying pathogenesis of portal hypertension. Also covered in this review are the randomized controlled trials and meta-analyses that involve a large number of patients. These trials involve relatively few drugs such as non-selective beta-blockers and nitrates. Correlations between haemodynamic and clinical parameters are discussed. Despite the recent increase in the use of alternative endoscopic therapies, an effective and well tolerated drug remains a clinically important research goal.

Entities:  

Mesh:

Year:  2001        PMID: 11207505     DOI: 10.1046/j.1365-2036.2001.00920.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  3 in total

1.  High-risk esophageal varices in patients treated with locoregional therapies for hepatocellular carcinoma: evaluation with regular follow-up liver CT.

Authors:  Hyojin Kim; Dongil Choi; Geum-Youn Gwak; Joon Hyeok Lee; Soon Jin Lee; Seong Hyun Kim; Ji Young Lee; Yulri Park; Ilsoo Chang; Hyo K Lim
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

Review 2.  Drugs used in therapy of portal hypertension.

Authors:  Dhiraj Tripathi
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-11-09

3.  Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension.

Authors:  Tamara Alempijevic; Vladislava Bulat; Srdjan Djuranovic; Nada Kovacevic; Rada Jesic; Dragan Tomic; Slobodan Krstic; Miodrag Krstic
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.